(Q42547509)

2 November 2017

Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure (English)

1 reference

2 November 2017

1 reference

Rulo AH

1

1 reference

2 November 2017

Greve EL

series ordinal

2

1 reference

2 November 2017

Hoyng PF

series ordinal

3

1 reference

2 November 2017

language of work or name

1 reference

1 September 1997

1 reference

2 November 2017

1 reference

2 November 2017

104

1 reference

2 November 2017

9

1 reference

2 November 2017

1503-1507

1 reference

Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2 alpha

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

Effects of topical PGF2 alpha on aqueous humor dynamics in cynomolgus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

Carbonic Anhydrase Inhibition and Aqueous Flow

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

Prostaglandin F2 alpha-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

Aplastic Anemia Following Acetazolamide Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

Carbonic anhydrase inhibitor side effects. Serum chemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

Patient tolerance to carbonic anhydrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930110-9

7 January 2021

10.1016/S0161-6420(97)30110-9

Identifiers

DOI

1 reference

2 November 2017

1 reference